Accelerated Fractionated Radiation Therapy for Localized Glottic Carcinoma

Bibliographic Details
Title: Accelerated Fractionated Radiation Therapy for Localized Glottic Carcinoma
Authors: Tatsuji Mizukami, Kentaro Yamagishi, Masaki Tobikawa, Akira Nakazato, Hideharu Abe, Yuka Morita, Jun-ichi Saitoh
Source: Current Oncology, Vol 31, Iss 5, Pp 2636-2643 (2024)
Publisher Information: MDPI AG, 2024.
Publication Year: 2024
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: glottic carcinoma, accelerated fractionated radiation therapy, laryngeal cancer, fractional dose, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Background: The aim of this study is to examine the outcomes of an accelerated fractionated irradiation for N0 glottic carcinoma. Methods: In this retrospective analysis, 29 patients with N0 glottic carcinoma treated by radiation therapy were enrolled. Thirteen patients had T1a disease, six had T1b disease, and ten had T2 disease. A fractional dose of 2.1 Gy was administered to seven patients. The total doses were 65.1 and 67.2 Gy in four and three patients, respectively. A fractional dose of 2.25 Gy was administered to 22 patients. The total doses were 63 and 67.5 Gy in 21 patients and 1 patient with T2 disease, respectively. Additionally, 13 patients underwent the use of TS-1 (80–100 mg per day). Results: The median follow-up period was 33 months, and the 3-year local control rate was 95.6%. No patient had a lymph node or distant recurrence. As acute adverse events, grades 2 and 3 dermatitis were observed in 18 patients and 1 patient, and grades 2 and 3 mucositis were observed in 15 patients and 1 patient. As a late adverse event, one patient required tracheotomy because of laryngeal edema occurring. Conclusions: Accelerated fractionated irradiation may be an option in the radiation therapy of N0 glottic carcinoma because of its ability to shorten the treatment time.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1718-7729
1198-0052
Relation: https://www.mdpi.com/1718-7729/31/5/198; https://doaj.org/toc/1198-0052; https://doaj.org/toc/1718-7729
DOI: 10.3390/curroncol31050198
Access URL: https://doaj.org/article/ae3d1528e953494baf924f166c09901d
Accession Number: edsdoj.3d1528e953494baf924f166c09901d
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:17187729
11980052
DOI:10.3390/curroncol31050198
Published in:Current Oncology
Language:English